Gregory K. Chow
Chief Financial Officer, Aptose Biosciences Inc.
Companies
- Sutro BiopharmaChief financial officer Jun 2, 2025 to now1
- Aptose Biosciences Inc.Chief financial officer Dec 21, 2018 to Jan 6, 20212
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Sutro Biopharma STRO4,725 shares3$53.3K at $11.28Jun 2, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 2, 2026Exercised options 2,500 shares of Sutro Biopharma3
- Oct 15, 2025Bought 19,750 shares at $0.81 of Sutro Biopharma4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Oct 16, 2025